Rapamycin Dosage, half-life & reference guide

Also known as Sirolimus · Rapamune · Rapa · mTOR inhibitor

Reviewed Evidence: EmergingPublished by PepVault

A transplant drug that turns down mTOR, the cell's growth switch. In mice it is the strongest lifespan drug found by the NIA's testing program, working in both sexes even when started late in life. In people, a year-long trial of 5–10 mg once a week found it about as safe as placebo, with lean mass and pain better in some women, while a 13-week trial in older adults saw slightly smaller exercise gains.

Studied range
5–10 mg
How often
Weekly
Half-life
~62 hours
Evidence
●●● Emerging
Route
Oral tablet

Studied in research — not a recommendation. FDA-approved (as sirolimus) for kidney-transplant rejection and lymphangioleiomyomatosis; longevity use is off-label.

How it works.

Rapamycin blocks mTOR, the switch cells use to decide between growing and maintaining themselves. Turning it down shifts cells toward repair and recycling (autophagy). At transplant doses taken every day it suppresses the immune system, which is what the FDA approved it for. The longevity idea is different: a low dose once a week, on the theory that brief, intermittent mTOR inhibition keeps the benefits seen in animals while sparing immunity. In the NIA's mouse lifespan program it extended life in both sexes, even when started late, more than any other drug tested. In people, no trial has measured lifespan; the trials so far tested safety, immunity and function.

Commonly reported: Occasional mouth sores and little else felt.

Half-life & active level

The half-life of Rapamycin is ~62 hours (62 ± 16 h after repeated dosing in kidney-transplant patients, FDA label); about 14% of an oral dose reaches the blood.

Here's how a typical Rapamycin schedule accumulates over four weeks (one-compartment estimate).

An estimate from the half-life above, not a measurement. See your own curve build live in the half-life calculator.

Your report

Taken Rapamycin? What did you notice?

One tap to start. About 30 seconds, no account.

A smiling woman with silver hair in a grey training top by a window, holding her phone

PepVault for iPhone

Track rapamycin in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week.

What to expect in the first 8 weeks

Onset
Not felt; the trials measure safety and markers over months
Peak effect
Not established in people
Duration
Trials ran 13–48 weeks
  1. Day 1–14Clinical

    A weekly pulse, not a daily brake

    The longevity pattern is one dose a week. Each dose peaks within a couple of hours and fades over the following days, so mTOR can recover before the next one. That on-off rhythm is the idea that separates it from transplant use.

    The science

    FDA label (sirolimus): peak at about 1–2 hours, terminal half-life 62 ± 16 hours after repeated dosing, oral availability about 14%. Transplant patients take 2–5 mg every day to a target blood level. The intermittent theory holds that weekly dosing inhibits mTORC1 briefly while limiting the immune and metabolic effects of continuous use; PEARL tested 5 and 10 mg weekly.

    Sources
    • FDA label, sirolimus tablets (2026)
    • Moel et al. (PEARL) (2025)

    Updated Nov 2026

  2. Day 14–90Clinical

    Mouth sores are the common signal

    The side effect people notice most is a small mouth sore now and then, the label's most common reaction. Blood fats and sugar can rise without being felt, which is what a lipid panel and glucose check catch.

    The science

    FDA label: stomatitis leads the most common adverse reactions in the LAM study (≥20%). Hypercholesterolemia occurred in 43–46% and hypertriglyceridemia in 45–57% of transplant patients against 23% on placebo, at daily doses with cyclosporine; hyperglycemia and diabetes are listed adverse reactions. In PEARL at weekly low doses, blood biomarkers stayed within normal ranges.

    Sources
    • FDA label, sirolimus tablets (2026)
    • Moel et al. (PEARL) (2025)

    Updated Nov 2026

  3. Any dayAnimal

    What rapamycin is built on

    Rapamycin is the strongest lifespan drug in mice: the NIA's testing program found it extends life in both sexes, even started late. In people the evidence is early: small trials of immunity, safety and function, and none of lifespan.

    The science

    ITP: Harrison 2009, fed from 600 days of age, +14% (females) and +9% (males) in age at 90% mortality at three sites; Miller 2011, from 9 months, median +10% males and +18% females. The 2025 review calls it the most effective intervention the ITP has identified. In older people, the rapalog everolimus raised the flu-vaccine response by about 20% (Mannick 2014), and low-dose TORC1 inhibition cut reported infections over a year in 264 elderly subjects (Mannick 2018). Low-dose rapamycin lowered p21, a senescence marker, in immune cells in a placebo-controlled study (Kell 2026).

    Sources
    • Harrison et al. (2009)
    • Miller et al. (2011)
    • Jiang et al. (2025)
    • Mannick et al. (2014)
    • Mannick et al. (2018)
    • Kell et al. (2026)

    Updated Nov 2026

  4. With MetforminAnimal

    Why metformin often rides along

    Rapamycin can nudge blood sugar up, and metformin lowers it, so the two are often paired. In the NIA's mice the combination extended life in both sexes, more than rapamycin alone did in males. The pair has not been tested together for aging in people.

    The science

    Strong 2016 (ITP): metformin (0.1% of diet) with rapamycin (14 ppm) robustly extended lifespan, by historical comparison with rapamycin alone; Jiang 2025 gives +23.6% (females) and +21.2% (males) median, from 9 months. Metformin alone did not extend lifespan by the log-rank test. The label lists hyperglycemia among rapamycin's adverse reactions.

    Sources
    • Strong et al. (2016)
    • Jiang et al. (2025)

    Updated Nov 2026

After week 8

  1. Day 90–336RCT

    What a year of weekly rapamycin showed

    In the PEARL trial, a year of 5 or 10 mg a week was about as safe as placebo. Visceral fat, the main measure, did not change; women on 10 mg gained lean tissue and reported less pain. A separate 13-week trial in people over 65 saw slightly smaller exercise gains on rapamycin.

    The science

    Moel 2025 (PEARL, NCT04488601; AgelessRx with UCLA, 129 enrolled): 48 weeks, placebo vs 5 or 10 mg compounded rapamycin weekly; adverse and serious adverse events similar; visceral adiposity unchanged (p = 0.942); lean tissue (p = 0.013) and pain (p = 0.015) improved in women on 10 mg. Stanfield 2026 (RAPA-EX-01): 40 adults aged 65–85, 6 mg weekly with home exercise for 13 weeks; chair stands −2.13 reps vs placebo (ITT p = 0.089; per-protocol −3.44, p = 0.007); 99 vs 63 adverse events.

    Sources
    • Moel et al. (PEARL) (2025)
    • Stanfield et al. (2026)

    Updated Nov 2026

Day 1 is the day you start it.

FDA label (sirolimus tablets, DailyMed Oct 2026); the NIA ITP mouse papers; small randomized trials of low-dose use in healthy older adults.

Preliminary research

A typical run.

Run notes

Cycle
The longevity pattern is intermittent: once a week (5 mg or 10 mg in PEARL, 6 mg in RAPA-EX-01), on the theory that a weekly pulse lets mTOR recover between doses. Trials ran 13–48 weeks. Some pause it around surgery because of the label's wound-healing warning.Community practice — opinions vary. Not a clinical recommendation.
Timing
The label asks for each dose to be taken the same way, consistently with or without food, because food changes how much is absorbed; never with grapefruit juice.
Route
Oral tablet
Stacks
Metformin

Track it in the app

Safety.

Common side effects

  • Mouth sores (stomatitis)
  • Higher cholesterol and triglycerides
  • Slower wound healing
  • Diarrhea or nausea
  • Acne

Interactions

Sirolimus is broken down by CYP3A4 and P-gp, so strong inhibitors (ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin) raise its levels and strong inducers (rifampin) lower them; the label says to avoid both, and not to take it with grapefruit juice. Vaccines may work less well, and live vaccines are avoided. Discuss every medication with your clinician.

Safety notes

A prescription drug. Its FDA label (as sirolimus) is for preventing kidney-transplant rejection and for lymphangioleiomyomatosis, at daily doses of 2–5 mg adjusted to blood levels, and carries a boxed warning: immunosuppression can raise the risk of infection, lymphoma and other cancers. The label also names impaired wound healing, fluid build-up, raised cholesterol and triglycerides, raised blood sugar, and lung inflammation (pneumonitis), rare but serious. Weekly low-dose use for aging is off-label: in the 48-week PEARL trial, adverse events at 5 or 10 mg a week were similar to placebo. Live vaccines are avoided while taking it, per the label. Discuss with your clinician, who can check lipids, glucose and blood counts.

Goes with.

Questions people ask.

What is Rapamycin?

A transplant drug that turns down mTOR, the cell's growth switch. In mice it is the strongest lifespan drug found by the NIA's testing program, working in both sexes even when started late in life. In people, a year-long trial of 5–10 mg once a week found it about as safe as placebo, with lean mass and pain better in some women, while a 13-week trial in older adults saw slightly smaller exercise gains.

How is Rapamycin dosed in research?

The research range for Rapamycin is 5–10 mg, weekly. Studied in research — not a recommendation. FDA-approved (as sirolimus) for kidney-transplant rejection and lymphangioleiomyomatosis; longevity use is off-label.

How long does Rapamycin last?

The half-life of Rapamycin is ~62 hours (62 ± 16 h after repeated dosing in kidney-transplant patients, FDA label); about 14% of an oral dose reaches the blood.

What do people report on Rapamycin?

Commonly reported on Rapamycin: occasional mouth sores and little else felt.

Is Rapamycin safe?

The research basis for Rapamycin is emerging: primarily preclinical / limited human data. Common side effects in the library: mouth sores (stomatitis), higher cholesterol and triglycerides, slower wound healing, diarrhea or nausea and acne.

What does Rapamycin stack with?

Common stacks for Rapamycin: Metformin.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Weekly

Half-life

~62 hours

~62 hours (62 ± 16 h after repeated dosing in kidney-transplant patients, FDA label); about 14% of an oral dose reaches the blood

Research basis

●●● Emerging

Primarily preclinical / limited human data

PepVault for iPhone

Track rapamycin in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library